Cytokinetics’ Failure In ALS Clears Way For Focus On Aficamten

 
• By Joseph Haas
  
change of focus
With its ALS program shuttered, Cytokinetics will put all focus on aficamten • Source: Shutterstock

More from Clinical Trials

More from R&D